NX PharmaGen (Louisville, KY) is developing molecular diagnostic tests for prenatal and oncology indications utilizing blood-based exosomal proteomics. Its NeXosome TM assays permit the early identification of pregnant women at-risk for preterm birth, as well as the time series evaluation of the molecular machinery of a tumor throughout the disease cycle.
NX PharmaGen
NX PharmaGen (Louisville, KY) is developing molecular diagnostic tests for prenatal and oncology indications utilizing blood-based exosomal proteomics. Its NeXosome TM assays permit the early identification of pregnant women at-risk for preterm birth, as well as the time series evaluation of the molecular machinery of a tumor throughout the disease cycle.
